No Data
No Data
Express News | Bionomics Ltd - Affirm-1 to Enroll 330 Adult Patients With Sad
Express News | Bionomics Ltd - Topline Results Are Expected in Q3 2025
Express News | Bionomics Ltd Files for Resale of up to 3.64 Mln Ordinary Shares by the Selling Shareholder - SEC Filing
Bionomics Announces Intention to Delist From the Australian Securities Exchange (ASX)
ADELAIDE, Australia and CAMBRIDGE, Mass., July 25, 2023 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO, NASDAQ:BNOX) (Bionomics or the Company) a clinical-stage biotechnology company developing nove
Bionomics Plans ASX Delisting; Shares Fall 41%
Bionomics (ASX:BNO) is planning to delist from the Australian bourse but will maintain its listing on NASDAQ. "[T]he costs and administrative burden of remaining listed on ASX outweigh any benefits of
Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?
No Data